During early treatment, many people find they cannot tolerate hot foods, large portions, or high-fat meals
In a 68- and 72-week clinical trial studying Wegovy (2.4 mg), brand-name Semaglutide, and Zepbound (15 mg), brand-name Tirzepatide, in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Daidzein is an isoflavone that has excellent antioxidant properties, although it has been proven unsuitable as a plant iron-chelating agent, as it does not chelate Fe 3+ (Dowling et al., 2010)
We combine clinical expertise with the convenience of telehealth to ensure you never have to navigate your weight loss journey alone